Preclinical correction of human Fanconi anemia complementation group A bone marrow cells using a safety-modified lentiviral vector

One of the major hurdles for the development of gene therapy for Fanconi anemia (FA) is the increased sensitivity of FA stem cells to free radical-induced DNA damage during ex vivo culture and manipulation. To minimize this damage, we have developed a brief transduction procedure for lentivirus vect...

Descripción completa

Detalles Bibliográficos
Autores principales: Becker, Pamela S., Taylor, Jason A., Trobridge, Grant D., Zhao, Xin, Beard, Brian C, Chien, Sylvia, Adair, Jennifer, Kohn, Donald B., Wagner, John E., Shimamura, Akiko, Kiem, Hans-Peter
Formato: Texto
Lenguaje:English
Publicado: 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927804/
https://www.ncbi.nlm.nih.gov/pubmed/20485382
http://dx.doi.org/10.1038/gt.2010.62

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927804/
https://www.ncbi.nlm.nih.gov/pubmed/20485382
http://dx.doi.org/10.1038/gt.2010.62

Ejemplares similares